Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism
Inebilizumab 可降低视神经脊髓炎谱系障碍的风险,且与 FCGR3A 多态性无关
期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.51911
Kim, Ho Jin; Aktas, Orhan; Patterson, Kristina R; Korff, Schaun; Kunchok, Amy; Bennett, Jeffrey L; Weinshenker, Brian G; Paul, Friedemann; Hartung, Hans-Peter; Cimbora, Daniel; Smith, Michael A; Mittereder, Nanette; Rees, William A; She, Dewei; Cree, Bruce A C